The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Theo Berkhout, Helen M. Simon, Dilip D. Patel, Craig Bentzen, Eric Niesor, Brian Jackson, Keith E. Suckling
Research output: Contribution to journal › Article › peer-review
40Citations
(Scopus)
Fingerprint
Dive into the research topics of 'The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase'. Together they form a unique fingerprint.